Biography:
Dr. Jocelyn Jakubik is a leading expert in immunology and vaccine development, currently serving as the head of Apex Pathogen Solutions supporting Assay Development for clients. With over two decades of experience across the pharmaceutical and non-profit sectors, she specializes in the creation of multiplex serology assays used for global disease surveillance and clinical trials. Her career is highlighted by significant leadership roles, including her tenure at the Sabin Vaccine Institute, where she managed high-containment research for BSL-4 viral vaccines funded by BARDA.
Dr. Jakubik earned her PhD in Immunology and Microbiology from Rush University Medical Center, focusing on HIV pathogenesis. Throughout her career at organizations such as Pfizer and PPD, she has been instrumental in advancing biofunctional assays for diverse viral targets, including SARS-CoV-2 and RSV. As of 2026, she remains at the forefront of the field, bridging the gap between innovative diagnostic technology and regulatory pathways for next-generation vaccines.
Title : Multiplexed serology assays for detection of IgG antibodies against Mpox and vaccinia viruses
Title : A novel multiplex serology assay to evaluate immune response to RSV, SARS CoV-2 and influenza